140 related articles for article (PubMed ID: 37230592)
1. The amino-dipeptidyl peptidases DPP8 and DPP9: Purification and enzymatic assays.
Donzelli L; Bolgi O; Geiss-Friedlander R
Methods Enzymol; 2023; 684():289-323. PubMed ID: 37230592
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
Zhang H; Chen Y; Keane FM; Gorrell MD
Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
[TBL] [Abstract][Full Text] [Related]
3. Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer.
Ross B; Krapp S; Augustin M; Kierfersauer R; Arciniega M; Geiss-Friedlander R; Huber R
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1437-E1445. PubMed ID: 29382749
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair.
Bolgi O; Silva-Garcia M; Ross B; Pilla E; Kari V; Killisch M; Spitzner M; Stark N; Lenz C; Weiss K; Donzelli L; Gorrell MD; Grade M; Riemer J; Urlaub H; Dobbelstein M; Huber R; Geiss-Friedlander R
EMBO Rep; 2022 Oct; 23(10):e54136. PubMed ID: 35912982
[TBL] [Abstract][Full Text] [Related]
5. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma.
Brunetti M; Holth A; Panagopoulos I; Staff AC; Micci F; Davidson B
Virchows Arch; 2019 Feb; 474(2):177-185. PubMed ID: 30467600
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
Chowdhury S; Chen Y; Yao TW; Ajami K; Wang XM; Popov Y; Schuppan D; Bertolino P; McCaughan GW; Yu DM; Gorrell MD
World J Gastroenterol; 2013 May; 19(19):2883-93. PubMed ID: 23704821
[TBL] [Abstract][Full Text] [Related]
8. Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells.
Zhang Y; Li K; Li Y; Zhao W; Wang L; Chen Z; Ma X; Yao T; Wang J; Dong W; Li X; Tian X; Fu R
Pharmacol Res; 2021 Jul; 169():105630. PubMed ID: 33932609
[TBL] [Abstract][Full Text] [Related]
9. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
[TBL] [Abstract][Full Text] [Related]
10. N-terminal processing by dipeptidyl peptidase 9: Cut and Go!
Zolg S; Donzelli L; Geiss-Friedlander R
Biochimie; 2024 Mar; ():. PubMed ID: 38461970
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
Huan Y; Jiang Q; Liu JL; Shen ZF
J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?
Van Goethem S; Matheeussen V; Joossens J; Lambeir AM; Chen X; De Meester I; Haemers A; Augustyns K; Van der Veken P
J Med Chem; 2011 Aug; 54(16):5737-46. PubMed ID: 21711053
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.
Zhang H; Maqsudi S; Rainczuk A; Duffield N; Lawrence J; Keane FM; Justa-Schuch D; Geiss-Friedlander R; Gorrell MD; Stephens AN
FEBS J; 2015 Oct; 282(19):3737-57. PubMed ID: 26175140
[TBL] [Abstract][Full Text] [Related]
14. Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism.
Wilson CH; Indarto D; Doucet A; Pogson LD; Pitman MR; McNicholas K; Menz RI; Overall CM; Abbott CA
J Biol Chem; 2013 May; 288(20):13936-13949. PubMed ID: 23519473
[TBL] [Abstract][Full Text] [Related]
15. Active site-directed probes targeting dipeptidyl peptidases 8 and 9.
Espadinha M; De Loose J; Corthaut S; Thys S; Van Rymenant Y; Verhulst E; Benramdane S; Filippi N; Augustyns K; Van Wielendaele P; Pintelon I; De Meester I; Van der Veken P
Eur J Med Chem; 2024 Apr; 270():116389. PubMed ID: 38593588
[TBL] [Abstract][Full Text] [Related]
16. DPP8/9 are not Required to Cleave Most Proline-Containing Peptides.
Bhattacharjee A; Bachovchin DA
Isr J Chem; 2023 Mar; 63(3-4):. PubMed ID: 37982048
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
Matheeussen V; Waumans Y; Martinet W; Van Goethem S; Van der Veken P; Scharpé S; Augustyns K; De Meyer GR; De Meester I
Basic Res Cardiol; 2013 May; 108(3):350. PubMed ID: 23608773
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase 9 (DPP9) in human skin cells.
Gabrilovac J; Čupić B; Zapletal E; Kraus O; Jakić-Razumović J
Immunobiology; 2017 Feb; 222(2):327-342. PubMed ID: 27682012
[TBL] [Abstract][Full Text] [Related]
19. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
[TBL] [Abstract][Full Text] [Related]
20. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
Rosenblum JS; Kozarich JW
Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
